期刊
CEPHALALGIA
卷 41, 期 3, 页码 279-293出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102421989247
关键词
Health technology assessment (HTA); migraine; acute therapy; preventive treatment; International Headache Society (IHS); position statement
The Health Technology Assessment by the Clinical Trials Subcommittee of the International Headache Society aims to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine, incorporating real-world evidence and a synthetic approach for assessing the value of migraine treatments using multiple data sources and modelling methods.
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. This position statement extends beyond the already available guidelines on randomized controlled trials for migraine to incorporate real-world evidence and a synthetic approach for considering multiple data sources and modelling methods when assessing the value of migraine treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据